New Approaches to Optimize Asparaginase Therapy in the Management of Acute Lymphoblastic Leukemia

Get up to date on the latest strategies for integrating asparaginase-containing chemotherapy regimens into the management of ALL in adolesent/young adult and adult patients with this educational program featuring an on-demand webcast and downloadable slidesets from a live CCO symposium along with a companion FAQ commentary where experts answer audience questions from the live program.

Share

Program Content

Activities

Asparaginase Hypersensitivity
Practical Considerations for Administration of Asparaginase-Based Therapy to Patients With ALL: Hypersensitivity or Intolerance or Inactivation?
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 07, 2022

Expires: June 06, 2023

Pediatric ALL Tx for AYA and Adults
Applying Lessons and Experience in Pediatric Patients to the Treatment of AYA and Adult Patients With ALL
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 06, 2022

Expires: June 05, 2023

Asparaginase Toxicities
Strategies to Mitigate Adverse Events With Asparaginase Treatment in Patients With ALL
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 06, 2022

Expires: June 05, 2023

No activities added yet

Activities

FAQ: Asparaginase in ALL
Asparaginase in AYA and Adult ALL: Expert Discussion of Frequently Asked Questions
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: August 23, 2022

Expires: August 22, 2023

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Jazz Pharmaceuticals, Inc.